BioCentury | Sep 14, 2015
Company News

Hemostemix, Hemostemix Asia deal

Hemostemix granted Hemostemix Asia rights to develop and commercialize ACP-01 in Taiwan, China and South Korea. Hemostemix Asia will fund and contribute up to 20 patients with critical limb ischemia (CLI) from three to five...
BioCentury | Aug 3, 2015
Company News

Hemostemix, Ludwig Boltzmann Institute deal

Hemostemix and Ludwig Boltzmann Institute (LBI) partnered to evaluate Hemostemix’s ACP-01 to restore blood supply. The partnership will evaluate ACP-01’s mechanism of action to optimize development. Hemostemix said it will pay LBI $45,000 to cover...
Items per page:
1 - 2 of 2